An engineered cereblon optimized for high throughput screening and molecular glue discovery
{{output}}
The majority of clinical degraders utilize an immunomodulatory imide drug (IMiD)-based derivative that directs their target to the E3 ligase receptor cereblon (CRBN); however, identification of IMiD molecular glue substrates has remained underexplored. To tack... ...
